2013-02-25 17:44:31 -
BB Biotech AG /
Director's Dealings announcement according to §15a WpHG (the German Securities
Trading Act)
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
--------------------------------------------------------------------------------
Name: Koller, Daniel
Professional role: Person with executive functions: Member of a managing
body
--------------------------------------------------------------------------------
Designation of the financial instrument
--------------------------------------------------------------------------------
ISIN: CH0038389992
Designation: Registered share BB Biotech AG
--------------------------------------------------------------------------------
Details of the transaction
--------------------------------------------------------------------------------
Type of transaction: Buy
Date: 21.02.2013
Place (stock exchange): SIX Swiss Exchange
Price: 96.85
Currency: CHF
Quantity: 200
Business volume: 19370
--------------------------------------------------------------------------------
Details of the company with the publishing obligation:
--------------------------------------------------------------------------------
Issuer:
BB Biotech AG
Vordergasse 3
CH-8200 Schaffhausen
Switzerland
ISIN: CH0038389992
WKN: 888509
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE
[HUG#1680881]
